← Back to all trials
Completed
NCT06752603
A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis
Conditions: Hunner Type Interstitial Cystitis
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE2
Enrollment: 57
Sponsor: Ono Pharmaceutical Co., Ltd.
Location: Nagoya University Hospital Nagoya Aichi-ken
Summary
To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Hunner Type Interstitial Cystitis
Eligibility Criteria
Inclusion Criteria:
* Japanese (both sexes)
* Age (at the time of informed consent): 18 years and older
* Outpatient
* Patients who are considered capable of understanding the study procedures and completing the pain diary, bladder diary, and questionnaires appropriately by the investigator (sub-investigator)
* Patients given a diagnosis of HIC by cystoscopy
* Patients with chronic pelvic pain involving the bladder and lower urinary tract symptoms such as increased micturition and pollakiuria
Exclusion Criteria:
* Patients with a history and presence of chemical cystitis
* Patients with a history of bladder augmentation or radical cystectomy
* Patients with pain other than HIC that may affect assessments in this study
* Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study
* Patients receiving medications for psychiatric disease
Source: ClinicalTrials.gov (NCT06752603). StuddyBuddy aggregates publicly available trial information.